Navigation Links
Advanced Life Sciences Announces Third Quarter 2008 Financial Results
Date:11/6/2008

96626416.

About Community Acquired Pneumonia (CAP)

CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. Approximately 5.6 million cases of CAP are diagnosed each year in the United States with 10 million physician visits, resulting in an estimated total annual expenditure of $2 billion dollars for prescribed antibiotics to treat CAP. CAP is potentially fatal if not treated properly, and the bacteria that cause CAP are developing resistance to current standard of care treatments.

Macrolides and penicillins are currently the front-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria, certain Gram-negative bacteria and atypical organisms associated with respiratory tract infections. In in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. Th
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC founder ... evaluating the full range of capabilities of its unique cache of technologies for ... the day-to-day renewal and repair of normal tissues and organs. This property makes ...
(Date:7/28/2015)... ... ... The new Xsample 530 sample changer for vials can be used with Anton ... from less than 12,000 mPas (internal air) up to 36,000 (external air) – and can ... eye about Xsample 530 is its removable magazine, which is easily lifted off its hub ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... EUR 1.022 billion in 2013; while production volume reached close to 1.84 million ... country with a share of 75.5% of the region’s total aluminium hydroxide production; ...
(Date:7/28/2015)... July 28, 2015 Deerfield Management Company, L.P. ... Fund, L.P., which will invest in groundbreaking advancements in ... diseases, cancer, and orphan diseases. The venture capital fund ... therapeutics are developed and improve the way healthcare is ... the largest healthcare-focused venture funds in the sector, will ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... TriLink BioTechnologies, Inc. (TriLink) and Lucigen Corporation (Lucigen) ... licensing agreement for the use of TriLink,s CleanAmp™ dNTPs ... TriLink,s CleanAmp™ dNTPs are an innovative approach to ... in a PCR assay with CleanAmp™ dNTPs, a Hot ...
...   Shire plc (LSE: SHP, NASDAQ: ... for the three months to June 30, 2011. ... $1,063 million +25% Non GAAP operating income $342 million +26% US ... ADS $1.33 +29% US GAAP diluted earnings per ADS $1.08 +26% ...
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), a biopharmaceutical ... for use in the hospital setting, today announced that it ... results on Wednesday, August 3, 2011. Cadence ... discuss the financial results on Wednesday, August 3, 2011 at ...
Cached Biology Technology:TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation 2Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 2Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 3Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 4Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 5Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 6Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 7Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 8Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 9Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 10Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 11Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 12Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 13Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 14Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 15Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 16Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 17Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 18Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 19Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 20Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 21Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 22Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 23Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 24Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 25Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 26Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 27Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 28Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 29Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 30Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 31
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... Tyco International Ltd. (NYSE: TYC ) today announced that it ... business. Tyco expects to file documents with the U.S. Securities & Exchange ... transaction in the first half of fiscal 2011. Following the transaction, the ... , , ...
... April 27, 2010 Dominio Amigo S.A.S , a .CO,accredited ... name launch. , , , ... Julio Camacho , CEO, Dominio Amigo S.A.S , commented, "Domainmonster was ... both ccTLD and gTLD launches, securing the very best Internet real estate,for their ...
... LONDON , April 27, 2010 Imperial Tobacco today,announces ... with online financial broadcaster http://www.cantos.com ,Chief Executive Gareth Davis ... our business and the success of our enhanced,focus on sales". , ... Davis hands ...
Cached Biology News:Tyco International To Pursue Spin-Off of Electrical & Metal Products Business 2Tyco International To Pursue Spin-Off of Electrical & Metal Products Business 3Dominio Amigo Announce Domainmonster as .CO Technical Partner 2Dominio Amigo Announce Domainmonster as .CO Technical Partner 3Imperial Tobacco - 2010 Half Year Results Interviews 2
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... ,Product Information , ,The ... quality, general purpose shaker with economical analog control. ... in the line, the Orbit LS features a ... controls are utilized for setting speed and time. ...
... CromoCenSC is a chromogenic medium for ... of Salmonella (except S. thyphi) and ... ,The detection takes a maximum of ... tests, no sterilization during preparation and ...
... provider of X-ray crystallography services for ... services to its pharmaceutical and biotechnology ... of drug-like fragments to the active ... allowing scientists to develop novel, high-affinity ...
Biology Products: